[化疗诱导的周围神经病变和性激素]
Tomoyoshi Miyamoto1,2, Maho Tsubota1, Fumiko Sekiguchi1
1Pharmacology and Pathophysiology, Faculty of Pharmacy, Kindai University.
Nihon yakurigaku zasshi. Folia pharmacologica Japonica
|March 1, 2026
概括
化疗诱导的周围神经病变 (CIPN) 是一个常见的副作用. 血栓素α (TMα) 通过降解HMGB1来防止CIPN,雌激素下降可能会增加女性的CIPN风险.
科学领域:
- 在瘤学瘤学.
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
背景情况:
- 化疗诱导的周围神经病变 (CIPN) 显著影响癌症患者的生活质量和治疗坚持.
- 细胞外高流动性组盒1 (HMGB1) 是CIPN发展的关键调解者.
- 阿尔法血栓模块素 (TMα) 降解HMGB1并显示出预防CIPN.的潜力.
研究的目的:
- 研究性激素在CIPN发育中的作用.
- 探索TMα作为CIPN的预防性干预的潜力.
主要方法:
- 对接受帕克利塔塞尔化疗的女性癌症患者进行了回顾性队列研究.
- 卵巢切除,雌激素补充和TMα治疗的CIPN动物模型.
- 在CIPN中探索性激素对HMGB1行为的影响 (正在进行中).
主要成果:
- 绝经后雌激素的下降被确定为CIPN发展或恶化的危险因素.
- 卵巢切除在动物模型中加剧了CIPN,这种影响被雌激素或TMα减轻.
- 有证据表明孕激素和雄激素也可能抑制CIPN或神经病痛.
结论:
- 性激素,特别是雌激素,可能对CIPN.起着保护作用.
- 性激素与年龄相关的下降可能会增加CIPN易感性.
- 对于高风险癌症患者,如绝经后妇女,TMα是一种有前途的预防疗法.
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
691
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
691
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
745
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
745
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
983
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
983
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
864
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
864
Drugs Affecting Neurotransmitter Synthesis
2.3K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.3K
Cancer Therapies
10.3K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.3K


